BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 26026171)

  • 1. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France.
    Choukri F; Botterel F; Sitterlé E; Bassinet L; Foulet F; Guillot J; Costa JM; Fauchet N; Dannaoui E
    Med Mycol; 2015 Aug; 53(6):593-6. PubMed ID: 26026171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
    J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
    van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
    J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
    Morio F; Aubin GG; Danner-Boucher I; Haloun A; Sacchetto E; Garcia-Hermoso D; Bretagne S; Miegeville M; Le Pape P
    J Antimicrob Chemother; 2012 Aug; 67(8):1870-3. PubMed ID: 22581906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.
    Jensen RH; Hagen F; Astvad KM; Tyron A; Meis JF; Arendrup MC
    Clin Microbiol Infect; 2016 Jun; 22(6):570.e1-9. PubMed ID: 27091095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran.
    Badali H; Vaezi A; Haghani I; Yazdanparast SA; Hedayati MT; Mousavi B; Ansari S; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2013 Nov; 56(6):659-63. PubMed ID: 23668594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan.
    Wang HC; Huang JC; Lin YH; Chen YH; Hsieh MI; Choi PC; Lo HJ; Liu WL; Hsu CS; Shih HI; Wu CJ; Chen YC
    Environ Microbiol; 2018 Jan; 20(1):270-280. PubMed ID: 29124846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
    J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
    J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
    Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
    J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.
    Liu M; Zeng R; Zhang L; Li D; Lv G; Shen Y; Zheng H; Zhang Q; Zhao J; Zheng N; Liu W
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4321-5. PubMed ID: 25896700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
    J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
    J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.
    Chen Y; Lu Z; Zhao J; Zou Z; Gong Y; Qu F; Bao Z; Qiu G; Song M; Zhang Q; Liu L; Hu M; Han X; Tian S; Zhao J; Chen F; Zhang C; Sun Y; Verweij PE; Huang L; Han L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5878-84. PubMed ID: 27431231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
    Riat A; Plojoux J; Gindro K; Schrenzel J; Sanglard D
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.